These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25832709)

  • 1. Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832709
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
    Barthelemy-Brichant N
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 5. In regard to Bogart et al.: 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage non-small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 (Int J Radiat Oncol Biol Phys 2004;59:460-468).
    Casas F; Jeremic B
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1661-2; author reply 1662-3. PubMed ID: 15590201
    [No Abstract]   [Full Text] [Related]  

  • 6. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 7. Erratum to: Melidis C, Bosch WR, Izewska J, et al. Global harmonization of quality assurance naming conventions in radiation therapy Clinical Trials. Int J Radiat Oncol Biol Phys 2014;90:1242-1249.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832708
    [No Abstract]   [Full Text] [Related]  

  • 8. Erratum to: Pignol J-P, Vu TTT, Mitera G, et al. Prospective Evaluation of Severe Skin Toxicity and Pain During Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys 2015;91:157-164.
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):702. PubMed ID: 26068501
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to: Routman DM, Funk RK, Tangsriwong K, et al. Relapse rates with surgery alone in human papillomavirus-related intermediate- and high-risk group oropharynx squamous cell cancer: A multi-institutional review. Int J Radiat Oncol Biol Phys 2017;99:938-946.
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1304. PubMed ID: 29722676
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation fields of neoadjuvant concurrent chemoradiotherapy for rectal cancer: in regard to Yu et al. (Int J Radiat Oncol Biol Phys 2008;71:1175-1180).
    Chien CR; Chen SW; Chen WT
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):639; author reply 639-40. PubMed ID: 19147033
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to: Gunther JR, Jimenez RB, Yechieli RL, et al. Introductory Radiation Oncology Curriculum: Report of a National Needs Assessment and Multi-institutional Pilot Implementation. Int J Radiat Oncol Biol Phys 2018;101:1029-1038.
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1602. PubMed ID: 31014796
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Mathilda L. Bongers, Veerle M.H. Coupé, Dirk De Ruysscher, Cary Oberije, Philippe Lambin, and Cornelia A. Uyl-de Groot. Individualized Positron Emission Tomography-Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy: A Model-Based Evaluation. Int J Radiat Oncol Biol Phys 2015;91:857-865.
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1175. PubMed ID: 26194686
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to: Wang SY, Kelly G, Gross C, et al. Information needs of older women with early-stage breast cancer when making radiation therapy decisions. Int J Radiat Oncol Biol Phys 2017;98:733-740.
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):532. PubMed ID: 29353665
    [No Abstract]   [Full Text] [Related]  

  • 17. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Cheung MR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Wallner PE, Anscher MS, Barker CA, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys 2014;88:11-17.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832710
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).
    Komaki R; Liao Z; Liu H; Tucker S; Rice D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1595-6; author reply 1596. PubMed ID: 17126220
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to: Hindley A, Zain Z, Wood L, et al. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 2014;90:748-755.
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):882. PubMed ID: 25752410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.